Table 3.
T2DM and Coagulation Test
| Variables | Non-T2DM(n=184) | T2DM(n=80) | P-value |
|---|---|---|---|
| R (min) | 5.20(4.30–6.20) | 5.00(4.23–5.90) | 0.499 |
| K (min) | 1.70(1.40–2.10) | 1.60(1.23–2.08) | 0.328 |
| Angle (deg) | 66.20(60.80–69.88) | 66.35(61.13–70.80) | 0.401 |
| MA (mm) | 63.90(59.20–67.50) | 64.80(60.55–68.63) | 0.099 |
| CI | 1.00(−0.30–2.00) | 1.25(−0.05–2.50) | 0.264 |
| MAA (mm) | 8.05(5.43–12.90) | 9.25(5.80–13.78) | 0.207 |
| MAADP (mm) | 26.80(15.63–39.65) | 37.50(19.50–51.48) | 0.001 |
| MAAA (mm) | 26.80(11.95–41.20) | 30.75(17.35–41.50) | 0.161 |
| AA-induced PIR (%) | 70.90(44.25–95.05) | 66.10(42.40–84.88) | 0.308 |
| ADP-induced PIR (%) | 65.95(43.98–87.70) | 47.70(24.65–79.23) | 0.004 |
| PT (sec) | 10.30(9.88–10.83) | 10.10(9.70–10.60) | 0.025 |
| PT-INR | 0.86(0.83–0.90) | 0.84(0.81–0.88) | 0.029 |
| APTT (sec) | 26.20(25.20–27.60) | 25.30(24.60–26.60) | <0.001 |
| FIB (g/L) | 3.23(2.73–3.85) | 3.28(2.76–4.17) | 0.412 |
| TT (sec) | 17.90(17.48–18.43) | 17.80(17.10–18.70) | 0.347 |
| AT-III (sec) | 93.70(85.80–102.80) | 96.80(89.70–102.00) | 0.336 |
| D-D (ug/L) | 0.51(0.41–0.66) | 0.59(0.45–0.73) | 0.050 |
| FDP (ug/L) | 1.00(0.70–1.40) | 1.10(0.70–1.80) | 0.358 |
Notes: Data are expressed as medians (25th and 75th percentiles). The significance of comparisons was determined by the Mann–Whitney U-test. Two-tailed P values <0.05 were considered statistically significant. Bold values indicate statistical significance.
Abbreviations: AA-induced PIR (%), arachidonic acid-induced platelet inhibition rate (%); ADP-induced PIR (%), adenosine diphosphate-induced platelet inhibition rate (%); PT, plasma prothrombin time; PT-INR, plasma prothrombin time international normalized ratio; APTT, activated partial thromboplastin time; FIB, fibrinogen content; TT, plasma prothrombin time measurement; AT-III, antithrombin-III; D-D, D-dimer; FDP, fibrin (pro)degradation product.